<VariationArchive VariationID="449630" VariationName="NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del)" VariationType="Deletion" Accession="VCV000449630" Version="31" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-07-15" DateCreated="2017-12-19" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="445592" VariationID="449630">
      <GeneList>
        <Gene Symbol="PIGQ" FullName="phosphatidylinositol glycan anchor biosynthesis class Q" GeneID="9091" HGNC_ID="HGNC:14135" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="569968" stop="584109" display_start="569968" display_stop="584109" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="619967" stop="634135" display_start="619967" display_stop="634135" Strand="+" />
          </Location>
          <OMIM>605754</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del)</Name>
      <CanonicalSPDI>NC_000016.10:578911:CTACT:CT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="578912" stop="578914" display_start="578912" display_stop="578914" variantLength="3" positionVCF="578911" referenceAlleleVCF="TCTA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="628912" stop="628914" display_start="628912" display_stop="628914" variantLength="3" positionVCF="628911" referenceAlleleVCF="TCTA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>Y400del</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004204.3" sequenceAccession="NM_004204" sequenceVersion="3" change="c.1199_1201del">
            <Expression>NM_004204.3:c.1199_1201del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.578914_578916del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.578914_578916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.628914_628916del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.628914_628916del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_034206.1" sequenceAccession="NG_034206" sequenceVersion="1" change="g.13947_13949del">
            <Expression>NG_034206.1:g.13947_13949del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004204.5" sequenceAccession="NM_004204" sequenceVersion="5" change="c.1199_1201del" MANESelect="true">
            <Expression>NM_004204.5:c.1199_1201del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004195.2" sequenceAccession="NP_004195" sequenceVersion="2" change="p.Tyr400del">
            <Expression>NP_004195.2:p.Tyr400del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_148920.4" sequenceAccession="NM_148920" sequenceVersion="4" change="c.1199_1201del">
            <Expression>NM_148920.4:c.1199_1201del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_683721.1" sequenceAccession="NP_683721" sequenceVersion="1" change="p.Tyr400del">
            <Expression>NP_683721.1:p.Tyr400del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA7780150" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="605754.0004" DB="OMIM" />
        <XRef Type="rs" ID="766667249" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del) AND not provided" Accession="RCV000518905" Version="18">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-01" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del) AND Inborn genetic diseases" Accession="RCV000624078" Version="5">
        <ClassifiedConditionList TraitSetID="25797">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-02-19" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del) AND Developmental and epileptic encephalopathy, 77" Accession="RCV000850141" Version="5">
        <ClassifiedConditionList TraitSetID="48647">
          <ClassifiedCondition DB="MedGen" ID="C5231405">Developmental and epileptic encephalopathy, 77</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-01-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004204.5(PIGQ):c.1199_1201del (p.Tyr400del) AND Epilepsy" Accession="RCV001240418" Version="6">
        <ClassifiedConditionList TraitSetID="8168">
          <ClassifiedCondition DB="MedGen" ID="C0014544">Epilepsy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-01" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-12-19" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31148362</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32588908</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Conflicting classifications of pathogenicity</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2020-07-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-09-16">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2019-09-16">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8168" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9566" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Seizure Disorders</ElementValue>
                <XRef ID="Seizure+Disorders/6488" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epilepsy</ElementValue>
                <XRef ID="MONDO:0005027" DB="MONDO" />
                <XRef ID="84757009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Seizure disorder</ElementValue>
                <XRef ID="11DG0893" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Citation Type="practice guideline" Abbrev="NICE, 2022">
                <URL>https://www.nice.org.uk/guidance/ng217</URL>
                <CitationText>UK NICE Guideline NG217, Epilepsies in children, young people and adults, 2022</CitationText>
              </Citation>
              <XRef ID="C0014544" DB="MedGen" />
              <XRef ID="D004827" DB="MeSH" />
              <XRef ID="MONDO:0005027" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="48647" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="42467" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 19</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605754.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 77</ElementValue>
                <XRef ID="MONDO:0032808" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 77</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DEE77</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EIEE77</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MCAHS4</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GPIBD19</ElementValue>
                <XRef Type="MIM" ID="618548" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16363" />
                <XRef ID="16363" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C5231405" DB="MedGen" />
              <XRef ID="MONDO:0032808" DB="MONDO" />
              <XRef Type="MIM" ID="618548" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="25797" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1940956" SubmissionDate="2021-01-26" DateLastUpdated="2021-01-30" DateCreated="2019-09-09">
        <ClinVarSubmissionID localKey="605754.0004_MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4" title="PIGQ, 3-BP DEL, 1199ACT_MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4" />
        <ClinVarAccession Accession="SCV000992305" DateUpdated="2021-01-30" DateCreated="2019-09-09" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-01-26">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the in-frame 3-bp deletion (c.1199_1201delACT) in the PIGQ gene, predicted to result in the deletion of conserved residue Tyr400 (Y400del), that was found in compound heterozygous state in a patient with multiple congenital anomalies-hypotonia-seizures syndrome-4 (MCAHS4; 618548) by Starr et al. (2019), see 605754.0004.</Attribute>
              <Citation>
                <ID Source="PubMed">31148362</ID>
              </Citation>
              <XRef DB="OMIM" ID="618548" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In female sibs (patients St3a and St3b) with MCAHS4, Johnstone et al. (2020) identified compound heterozygous mutations in the PIGQ gene: Y400del and a 2-bp deletion (c.1578_1579del; 605754.0005) predicted to result in a frameshift and premature termination (Gln527AlafsTer75). The mutations were identified by whole-exome sequencing. Each parent was heterozygous for one of the mutations. Flow cytometry in fibroblasts from patient St3b showed decreased FLAER and decreased CD73 (129190) and CD109 (608859) GPI-anchored proteins. Transduction with a lentivirus containing wildtype PIGQ restored GPI-anchored protein expression.</Attribute>
              <Citation>
                <ID Source="PubMed">32588908</ID>
              </Citation>
              <XRef DB="OMIM" ID="129190" Type="MIM" />
              <XRef DB="OMIM" ID="608859" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a patient (patient St2) with MCAHS4, Johnstone et al. (2020) identified compound heterozygous mutations in the PIGQ gene: Y400del and a c.942+1G-A mutation in intron 4 (IVS4+1G-A; 605754.0006), predicted to disrupt a canonical splice site. The mutations were identified by whole-exome sequencing. Each parent was heterozygous for one of the mutations. Flow cytometry in fibroblasts from the patient showed decreased CD59 (107271) expression.</Attribute>
              <Citation>
                <ID Source="PubMed">32588908</ID>
              </Citation>
              <XRef DB="OMIM" ID="107271" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGQ" />
          </GeneList>
          <Name>PIGQ, 3-BP DEL, 1199ACT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">3-BP DEL, 1199ACT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="605754.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1204354" SubmissionDate="2022-03-02" DateLastUpdated="2023-03-04" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="GDXSV:221992" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000617942" DateUpdated="2023-03-04" DateCreated="2017-12-19" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>In-frame deletion of one amino acid in a non-repeat region; In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 27513193, 31148362, 32746448)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGQ" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:819661</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004204.3:c.1199_1201del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_92_20220302054205</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2748431" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="2263618|MedGen:C0014544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001413356" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31148362</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32588908</ID>
          </Citation>
          <Comment>This variant, c.1199_1201del, results in the deletion of 1 amino acid(s) of the PIGQ protein (p.Tyr400del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs766667249, gnomAD 0.03%). This variant has been observed in individual(s) with PIGQ-related conditions (PMID: 31148362, 32588908). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 449630). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.628912_628914del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0014544" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1444676" SubmissionDate="2024-04-20" DateLastUpdated="2024-05-01" DateCreated="2018-04-15">
        <ClinVarSubmissionID localKey="a658855|MedGen:C0950123" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000740884" DateUpdated="2024-05-01" DateCreated="2018-04-15" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32588908</ID>
          </Citation>
          <Comment>The c.1199_1201delACT (p.Y400del) alteration is located in exon 6 (coding exon 5) of the PIGQ gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions 1199 and 1201, resulting in the deletion of a tyrosine (Y) at amino acid position 400. Based on data from the Genome Aggregation Database (gnomAD) database, the PIGQ c.1199_1201delACT alteration was observed in 0.014% (40/281,686) of total alleles studied, with a frequency of 0.03% (37/128,562) in the European (non-Finnish) subpopulation. The p.Y400del alteration has been reported in trans with a second PIGQ alteration in multiple patients with infantile epileptic encephalopathy (Johnstone, 2020). The p.Y400 amino acid is conserved in available vertebrate species. The p.Y400 amino acid is located in the third transmembrane region of the PIGQ catalytic domain. The p.Y400del alteration is predicted to be deleterious with a score of -16.01 by PROVEAN in silico analysis. Based on the available evidence, this alteration is classified as likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_148920.1:c.1199_1201delACT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>AVA4 Submission_Through01042023</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava4_2</SubmissionName>
          <SubmissionName>NovelandUpdateExomeDeposit_ExomeProgenyThrough080120</SubmissionName>
          <SubmissionName>exome clinvar deposit 2.18.18</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4719167" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2022-04-08">
        <ClinVarSubmissionID localKey="113880|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002497832" DateUpdated="2024-07-15" DateCreated="2022-04-08" Type="SCV" Version="15" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>PIGQ: PM3:Very Strong, PM2, PM4, PS3:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="4" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PIGQ" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="16" alternateAllele="T" referenceAllele="TCTA" start="628911" stop="628914" variantLength="4" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2748431" TraitType="Disease" MappingType="XRef" MappingValue="C0014544" MappingRef="MedGen">
        <MedGen CUI="C0014544" Name="Epilepsy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1444676" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4719167" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1204354" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1940956" TraitType="Disease" MappingType="Name" MappingValue="MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 4" MappingRef="Preferred">
        <MedGen CUI="C5231405" Name="Developmental and epileptic encephalopathy, 77" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

